In this FOIA request, we sought additional information regarding mifepristone safety data, including Q3 FAERS data and case reports created by FDA scientists reviewing FAERS data. In addition we requested data that FDA may have acquired to do its ongoing review of mifepristone.

Submitted: 1/28/2026
30-day response due: 3/11/2026